Fingerprint
Dive into the research topics of 'Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically